Propios 100mg/ml 10ml Vial by Driada Medical

Usage

1. Plan your full cutting cycle duration (typically 8–12 weeks) and calculate total vial requirements at your chosen EOD dose before ordering, so supply interruptions do not break injection continuity.
2. Draw your dose using a 1 ml insulin syringe for precision — 0.5 ml = 50 mg, 1.0 ml = 100 mg — then switch to a 23–25 gauge, 1-inch needle for the intramuscular injection to minimise injection-site trauma.
3. Rotate injection sites systematically (left glute, right glute, lateral deltoid) across each EOD schedule to prevent localised oil accumulation and scar tissue buildup, which is especially important over a 12-week cut.
4. Administer your aromatase inhibitor on the day of or day after each injection, titrating to blood-test estradiol results rather than a fixed dose, to keep subcutaneous water retention at its minimum during the lean phase.
5. Track bodyweight, waist measurement, and conditioning photos weekly; the fast ester means visible physique responses to dose adjustments typically appear within 7–10 days, giving actionable feedback during the cut.
6. Time your final injection 3–5 days before beginning post-cycle therapy so the short ester has cleared sufficiently and the SERM can engage effectively without competing androgen suppression.

Warnings

Frequently asked questions

Is Testosterone Propionate effective for a cutting cycle, or is it mainly a bulking compound?

Testosterone propionate is highly effective for cutting. Its primary role in a caloric deficit is anti-catabolic: it maintains androgen-receptor occupancy so that muscle protein is spared even when energy intake is restricted. Because the short ester produces minimal water retention compared to longer formats, it adds lean androgenic support without masking the visual definition athletes are working toward during a cut.

How should Propios 100mg/ml be dosed specifically for a lean-phase protocol?

Most cutting protocols place Propios at 50–100 mg per injection on an every-other-day schedule, yielding 175–350 mg of total testosterone per week. Lower doses — closer to 50 mg EOD — are preferred in the final four to six weeks when water and estrogen control become critical for contest conditioning. This range maintains serum testosterone well above the catabolic threshold without driving aggressive aromatisation.

Which compounds pair best with Testosterone Propionate during a definition phase?

Non-aromatising androgens are the natural partners for propionate during a cut. Methenolone enanthate (Primobolan), masteron propionate, and low-dose stanozolol are most commonly stacked because they add anabolic stimulus without contributing additional estrogen substrate. Matching propionate with other short esters also aligns half-lives, so all compounds clear on a similar schedule when the cycle ends.

Can I draw accurate cutting doses from a 10ml vial using an insulin syringe?

Yes — the 100 mg/ml concentration of Propios makes insulin-syringe dosing straightforward. A 0.5 ml draw equals exactly 50 mg, and a 1.0 ml draw delivers 100 mg; both volumes sit within the working range of a standard 1 ml insulin syringe. This linear dose-to-volume relationship reduces measurement error, which matters during a cut when consistent androgenic exposure directly influences weekly conditioning outcomes.

How should a 10ml vial of Propios be stored once opened, and what is its shelf life after first puncture?

After the first draw, store the vial upright at 2–8 °C and use within 28 days; the bromobutyl rubber stopper maintains a sterile barrier across multiple withdrawals when standard aseptic technique is followed. Always inspect the solution before each draw — discard if particulate matter appears or if the oil becomes cloudy. Unopened vials should be kept away from direct light and heat to preserve full potency through the printed expiry date. (2) angle_used

Manufacturer

Driada Medical has built a targeted specialisation in short and medium-chain esterified testosterone compounds, with Propios representing the brand's dedicated offering within the propionate ester category specifically — not a broadened general-androgen line, but a focused response to the demand for a rigorously documented testosterone propionate formulation. The specialisation extends into the analytical layer: finished-product lots of Propios are characterised by reversed-phase HPLC against a certified testosterone propionate reference standard, with concentration acceptance criteria set to ±5 % of the declared 100 mg/ml label claim, a tighter specification than many compounding-class producers apply. Endotoxin burden is quantified via LAL (Limulus Amebocyte Lysate) methodology before any batch proceeds to release, with limits aligned to the Ph. Eur. parenteral endotoxin threshold for the declared dose volume. This ester-specific documentation approach means that Driada Medical's internal assay library for propionate accumulates cycle-over-cycle trending data — enabling the quality team to detect formulation drift across consecutive batches before any deviation reaches a customer.